Through the festive season, the British Luxury Brand Burberry reports strong sales growth. Increased sales from Asia region up by 36% to £210m, increased sales from Europe region grew by 20% to 160m. Increased sales up by 13% in the period from its flagship stores London, Paris, Las Vegas and Hong Kong.
Analyst forecasts the company to meet a full year profit before tax of £375m.
Burberry's signature outerwear and leather goods drove half of its total retail growth of 21% to £574m in the three month end of December.
From the peak in July Burberry's shares had knocked by 20% due to fears of a slow down in Asia but investors were reassured that the reported comparable store sales in China had grown by 30% in the quarter.
The company's licensing revenue grew by 12% in the third quarter which led by a 60% growth in its fragrance, eyewear and watches division. Due to the successful launch of Burberry Body, a new perfume, the company is driven to aim on the introduction of sunglasses and watches.
Ms Cartwright said as the company is considering different licensing arrangement which could include 'buy in' potentials further talks with Inter Parfums over the licensing agreement continues.
Analyst forecasts the company to meet a full year profit before tax of £375m.
Burberry's signature outerwear and leather goods drove half of its total retail growth of 21% to £574m in the three month end of December.
From the peak in July Burberry's shares had knocked by 20% due to fears of a slow down in Asia but investors were reassured that the reported comparable store sales in China had grown by 30% in the quarter.
The company's licensing revenue grew by 12% in the third quarter which led by a 60% growth in its fragrance, eyewear and watches division. Due to the successful launch of Burberry Body, a new perfume, the company is driven to aim on the introduction of sunglasses and watches.
Ms Cartwright said as the company is considering different licensing arrangement which could include 'buy in' potentials further talks with Inter Parfums over the licensing agreement continues.
No comments:
Post a Comment